DISSEMINATED RHIZOPUS INFECTION IN A PREMATURE-INFANT

被引：22

作者：

CRAIG, NM ^{[1
]}

LEUDER, FL ^{[1
]}

PENSLER, JM ^{[1
]}

BEAN, BS ^{[1
]}

PETRICK, ML ^{[1
]}

THOMPSON, RB ^{[1
]}

ERAMO, LR ^{[1
]}

机构：

[1] NORTHWESTERN UNIV,SCH MED,DEPT DERMATOL,CHICAGO,IL 60611

来源：

PEDIATRIC DERMATOLOGY | 1994年 / 11卷 / 04期

关键词：

D O I：

10.1111/j.1525-1470.1994.tb00103.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

A 16-day-old premature male infant developed rapidly expanding necrotic facial plaques. Histology and cultures of tissue biopsy specimens revealed infection with Rhizopus arrhizius. The patient was treated aggressively with surgical debridement, amphotericin B, and rifampin, but had a progressive spread of the cutaneous infection and a fatal clinical course. He had gastrointestinal and pulmonary involvement on autopsy. Zygomycoses are rapidly progressive infections which generally affect immunocompromised hosts. Premature infants should be included as individuals at risk for disseminated zygomycotic disease.

引用

页码：346 / 350

页数：5

共 27 条

[1]

McGinnis MR, Ajello L, Schell WA., Mycotic disease: a proposed nomenclature, Int J Dermatol, 24, pp. 9-15, (1985)

[2]

Rinaldi MG., Zygomycosis, Infect Dis Clin North Am, 3, pp. 19-41, (1989)

[3]

Lefarer RI, Howard DH, Sypherd PS, Edwards JE, Segal GP, Winston DJ., Mucormycosis, Ann Intern Med, 93, pp. 93-108, (1980)

[4]

Rippon JW., Medical mycology: the pathogenic fungi and the pathogenic actinomycetes, pp. 681-713, (1988)

[5]

Wong B, Armstrong D., Clinical manifestations and management of mucormycosis in the compromised patient, Fungal infection in the compromised patient, pp. 153-190, (1991)

[6]

Parfrey NG., Improved diagnosis and prognosis of mucormycosis: a clinicopathologic study of 33 cases, Medicine, 65, pp. 113-123, (1986)

[7]

Radentz WH., Opportunistic fungal infections in immunocompromised hosts, J Am Acad Dermatol, 20, pp. 989-1001, (1989)

[8]

Ingram CW, Sennesh J, Cooper JN, Perfect JR., Disseminated zygomycosis: report of four cases and review, Rev Infect Dis, 11, pp. 741-754, (1989)

[9]

Daly AL, Velaquez LA, Bradley SF, Kaufman CA., Mucormycoses: association with deferoxamine therapy, Am J Med, 87, pp. 468-471, (1989)

[10]

Cutesen JV, Boelart JR., Effects of deferoxamine, feroxamine, and iron on experimental mucormycosis (zygomycosis), Kidney Int, 36, pp. 1061-1068, (1989)

← 1 2 3 →